{"id":1885,"date":"2014-03-24T20:51:35","date_gmt":"2014-03-24T20:51:35","guid":{"rendered":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?p=1885"},"modified":"2014-05-06T11:13:04","modified_gmt":"2014-05-06T11:13:04","slug":"hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark","status":"publish","type":"post","link":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/","title":{"rendered":"Hormonersatz-Therapie in der fr\u00fchen Postmenopause: Neues aus D\u00e4nemark"},"content":{"rendered":"<p>AMB 2012,\u00a046, 83 &nbsp; Hormonersatz-Therapie in der fr\u00fchen Postmenopause: Neues aus D\u00e4nemark &nbsp; Fazit:\u00a0\u00a0Eine schon 1990 begonnene Studie aus D\u00e4nemark zur Hormonersatz-Therapie bei Frauen in der fr\u00fchen Postmenopause mit einer Laufzeit von 10\u00a0Jahren und mit 5\u00a0Jahren Nachbeobachtung ergab weniger Herzinfarkte, Todesf\u00e4lle und station\u00e4re &#8230; Bitte abonnieren oder Kennlernartikel anfordern &#8211;&gt; &nbsp; Schlagworte zum Artikel: DOPS-Studie,\u00a0Estrogene,\u00a0Estrogene\/Gestagene,\u00a0Gestagene,\u00a0Hormonersatz-Therapie,\u00a0HRT,Klimakterium, [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AMB 2012,\u00a046, 83 &nbsp; Hormonersatz-Therapie in der fr\u00fchen Postmenopause: Neues aus D\u00e4nemark &nbsp; Fazit:\u00a0\u00a0Eine schon 1990 begonnene Studie aus D\u00e4nemark zur Hormonersatz-Therapie bei Frauen in der fr\u00fchen Postmenopause mit einer Laufzeit von 10\u00a0Jahren und mit 5\u00a0Jahren Nachbeobachtung ergab weniger Herzinfarkte, Todesf\u00e4lle und station\u00e4re &#8230; Bitte abonnieren oder Kennlernartikel anfordern &#8211;&gt; &nbsp; Schlagworte zum Artikel: DOPS-Studie,\u00a0Estrogene,\u00a0Estrogene\/Gestagene,\u00a0Gestagene,\u00a0Hormonersatz-Therapie,\u00a0HRT,Klimakterium, [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[722,1022],"tags":[1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033],"class_list":["post-1885","post","type-post","status-publish","format-standard","hentry","category-jahr-2012-band-46","category-monat-11-jahr-2012-band-46","tag-dops-studie","tag-estrogene","tag-estrogenegestagene","tag-gestagene","tag-hormonersatz-therapie","tag-hrt","tag-klimakterium","tag-menopause","tag-oestrogene","tag-oestrogenegestagene","tag-postmenopause"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hormonersatz-Therapie in der fr\u00fchen Postmenopause: Neues aus D\u00e4nemark<\/title>\n<meta name=\"description\" content=\"Hormonersatz-Therapie in der fr\u00fchen Postmenopause - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken --&gt;\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hormonersatz-Therapie in der fr\u00fchen Postmenopause: Neues aus D\u00e4nemark\" \/>\n<meta property=\"og:description\" content=\"Hormonersatz-Therapie in der fr\u00fchen Postmenopause - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken --&gt;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/\" \/>\n<meta property=\"og:site_name\" content=\"Der Arzneimittelbrief\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/derarzneimittelbrief.de\" \/>\n<meta property=\"article:published_time\" content=\"2014-03-24T20:51:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2014-05-06T11:13:04+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg\" \/>\n<meta name=\"author\" content=\"henk-amb\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"henk-amb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\\\/\"},\"author\":{\"name\":\"henk-amb\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/2e7981c97826a4941311e607c145d937\"},\"headline\":\"Hormonersatz-Therapie in der fr\u00fchen Postmenopause: Neues aus D\u00e4nemark\",\"datePublished\":\"2014-03-24T20:51:35+00:00\",\"dateModified\":\"2014-05-06T11:13:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\\\/\"},\"wordCount\":617,\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\",\"keywords\":[\"DOPS-Studie\",\"Estrogene\",\"Estrogene\\\/Gestagene\",\"Gestagene\",\"Hormonersatz-Therapie\",\"HRT\",\"Klimakterium\",\"Menopause\",\"\u00d6strogene\",\"\u00d6strogene\\\/Gestagene\",\"Postmenopause\"],\"articleSection\":[\"Jahr 2012 Band 46\",\"Monat 11\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\\\/\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\\\/\",\"name\":\"Hormonersatz-Therapie in der fr\u00fchen Postmenopause: Neues aus D\u00e4nemark\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\",\"datePublished\":\"2014-03-24T20:51:35+00:00\",\"dateModified\":\"2014-05-06T11:13:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/2e7981c97826a4941311e607c145d937\"},\"description\":\"Hormonersatz-Therapie in der fr\u00fchen Postmenopause - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\\\/#primaryimage\",\"url\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\",\"contentUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hormonersatz-Therapie in der fr\u00fchen Postmenopause: Neues aus D\u00e4nemark\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\",\"name\":\"Der Arzneimittelbrief\",\"description\":\"Unabh\u00e4ngige Arzneimittelinformationen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/2e7981c97826a4941311e607c145d937\",\"name\":\"henk-amb\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g\",\"caption\":\"henk-amb\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hormonersatz-Therapie in der fr\u00fchen Postmenopause: Neues aus D\u00e4nemark","description":"Hormonersatz-Therapie in der fr\u00fchen Postmenopause - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/","og_locale":"de_DE","og_type":"article","og_title":"Hormonersatz-Therapie in der fr\u00fchen Postmenopause: Neues aus D\u00e4nemark","og_description":"Hormonersatz-Therapie in der fr\u00fchen Postmenopause - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","og_url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/","og_site_name":"Der Arzneimittelbrief","article_publisher":"http:\/\/www.facebook.com\/derarzneimittelbrief.de","article_published_time":"2014-03-24T20:51:35+00:00","article_modified_time":"2014-05-06T11:13:04+00:00","og_image":[{"url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","type":"","width":"","height":""}],"author":"henk-amb","twitter_misc":{"Verfasst von":"henk-amb","Gesch\u00e4tzte Lesezeit":"3\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/#article","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/"},"author":{"name":"henk-amb","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/2e7981c97826a4941311e607c145d937"},"headline":"Hormonersatz-Therapie in der fr\u00fchen Postmenopause: Neues aus D\u00e4nemark","datePublished":"2014-03-24T20:51:35+00:00","dateModified":"2014-05-06T11:13:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/"},"wordCount":617,"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/#primaryimage"},"thumbnailUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","keywords":["DOPS-Studie","Estrogene","Estrogene\/Gestagene","Gestagene","Hormonersatz-Therapie","HRT","Klimakterium","Menopause","\u00d6strogene","\u00d6strogene\/Gestagene","Postmenopause"],"articleSection":["Jahr 2012 Band 46","Monat 11"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/","name":"Hormonersatz-Therapie in der fr\u00fchen Postmenopause: Neues aus D\u00e4nemark","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/#primaryimage"},"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/#primaryimage"},"thumbnailUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","datePublished":"2014-03-24T20:51:35+00:00","dateModified":"2014-05-06T11:13:04+00:00","author":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/2e7981c97826a4941311e607c145d937"},"description":"Hormonersatz-Therapie in der fr\u00fchen Postmenopause - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","breadcrumb":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/#primaryimage","url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","contentUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/hormonersatz-therapie-der-fruehen-postmenopause-neues-aus-daenemark\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/"},{"@type":"ListItem","position":2,"name":"Hormonersatz-Therapie in der fr\u00fchen Postmenopause: Neues aus D\u00e4nemark"}]},{"@type":"WebSite","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/","name":"Der Arzneimittelbrief","description":"Unabh\u00e4ngige Arzneimittelinformationen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/2e7981c97826a4941311e607c145d937","name":"henk-amb","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g","caption":"henk-amb"}}]}},"_links":{"self":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/1885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/comments?post=1885"}],"version-history":[{"count":5,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/1885\/revisions"}],"predecessor-version":[{"id":2108,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/1885\/revisions\/2108"}],"wp:attachment":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/media?parent=1885"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/categories?post=1885"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/tags?post=1885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}